Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

GLP-1 Side Effects in Women: The Whole Map, Head to Toe

Every women's GLP-1 side effect I've written about, from periods and hair to reflux, smells and loose skin, with what the labels and studies actually show.

Written by — editorial research, not medical advice
On this page

Why I made a map

Over the past year I have written about almost every side effect women ask me about, one guide at a time. That left the answers scattered, so this page puts them in one place, roughly head to toe, with one line on what the evidence shows and a link to the longer piece.

Most of what follows comes from the Wegovy and Zepbound prescribing labels. Where a label says nothing, I say so, because "nobody has studied it" is an honest answer and not a reason to panic.

What the labels actually counted

Side effectWegovy 2.4 mg vs placeboZepbound 5–15 mg vs placebo
Nausea44% vs 16%25–29% vs 8%
Constipation24% vs 11%11–17% vs 5%
Fatigue11% vs 5%5–7% vs 3%
Reflux (GERD)5% vs 3%4–5% vs 2%
Hair loss3% vs 1%4–5% vs 1%

Sources: the Wegovy1 and Zepbound2 prescribing information.

Hair, skin and face

Hair loss is the one side effect the labels report separately for women, and both drugs show it more often in women than in men: 7.1% of women versus 0.5% of men on Zepbound, and 4% versus 0.9% on Wegovy 2.4 mg2,1. My notes on hair loss and what helped cover shedding timelines, and the Ozempic face piece covers volume changes. Neither label lists facial change as a side effect.

Skin questions are less studied. I wrote separately about acne after starting a GLP-1 and about loose skin after fast weight loss, which no GLP-1 trial has measured directly. The Wegovy pen instructions also ask you to avoid scars and stretch marks, which my injection-site guide explains for moms with a lot of both. Rotating sites each week is on every label.

Mouth, smell and taste

The labels don't track tooth sensitivity with reflux, but stomach acid reaching the mouth is a plausible link worth raising with a dentist. Changes in urine and body odor and in intimate taste are mostly anecdotal so far. I treat those pages as question lists, not findings.

Food aversions come up constantly in the messages I get. The appetite effect is the drug working, but it can make eating enough harder.

Stomach and bowels

This is where most side effects live. Nausea, vomiting and diarrhea are the top items on both labels, and I put the general relief steps in managing GLP-1 side effects. When nausea won't settle, my piece on nausea versus gastroparesis explains the warning signs. Most stomach effects are worst in the weeks after a dose increase.

Constipation affected about a quarter of people on Wegovy 2.4 mg in the trials1. The fixes I would try first are in constipation relief and warning signs, and straining can lead to hemorrhoids and bleeding, which always deserves a check. Blood in the toilet is never something to wait out.

Reflux is lower on the list but miserable at night, so I wrote about nighttime reflux and the eggy sulfur burps separately. Feeling bloated and not wanting to be touched is a real effect on intimacy, not vanity. Severe or constant stomach pain is a call-today symptom, because both labels warn about pancreatitis and gallbladder disease1,2. Pain that spreads to the back is one to mention by name.

Periods, breasts and fertility

The labels don't report menstrual changes as an adverse reaction, but weight loss itself can shift a cycle. I covered cycle changes on a GLP-1 and the specific worry of a missed period, which should start with a pregnancy test. Breast size often changes with weight, and my breast and nipple changes guide explains what to get checked. A new lump is a doctor visit whatever medicine you take.

Contraception is the one with a hard rule. The Zepbound label asks for backup to the pill for four weeks after starting and after each increase2, which I explained in Zepbound and birth control, while the semaglutide labels carry no such warning. Wegovy should be stopped at least two months before a planned pregnancy1.

Vaginal dryness and libido

No trial has measured these well. My vaginal dryness and libido guide separates what may come from hormones, eating less or perimenopause from what anyone has shown about the drugs. It's a common conversation and a fair one to bring to a gynecologist.

Energy, mood and heart

Fatigue roughly doubled versus placebo on Wegovy, at 11% versus 5%1. My fatigue guide walks through the usual causes to rule out, starting with simply eating too little. Both labels removed their suicidal-thoughts warning in February 20261,2, but feeling flat or moody for weeks still deserves a call. Low mood is a symptom, not a character flaw.

Both labels also say to watch for a faster resting heartbeat, and on Zepbound the average rise was 1 to 3 beats per minute2. I wrote up heart rate and palpitations with the symptoms worth reporting quickly. A racing heart with chest pain or fainting is an emergency.

Muscle and bone

Lean mass falls along with fat, which I went through scan by scan in muscle loss and strength training. In Wegovy's heart trial, hip and pelvic fractures were more common in women on the drug than on placebo, 1% versus 0.2%1, so my bone health in women guide is worth reading before menopause, not after. Strength training helps both muscle and bone.

Where to start

If you only read one more page, the women's side-effect roundup goes deeper on hair, mood and lean tissue. Anything severe, such as pain that won't stop, vomiting that keeps you from drinking, or thoughts of harming yourself, means calling your prescriber, 988 or 911 today.

Frequently asked questions

What are the most common GLP-1 side effects in women?

The same stomach effects as in men lead the labels: on Wegovy 2.4 mg, nausea affected 44% versus 16% on placebo and constipation 24% versus 11%. Hair loss is the side effect both labels report more often in women, at 7.1% of women versus 0.5% of men on Zepbound and 4% versus 0.9% on Wegovy 2.4 mg.

Do GLP-1s affect your period?

The Wegovy and Zepbound labels do not list menstrual changes as an adverse reaction, but weight loss itself can change a cycle and fertility can return as weight comes off. A missed period on a GLP-1 should start with a pregnancy test.

Do GLP-1s interfere with birth control?

Tirzepatide does for a while: the Zepbound and Mounjaro labels ask for a non-oral or backup method for 4 weeks after starting and after each dose increase. The Wegovy and Ozempic labels carry no such warning, although vomiting or diarrhea can still affect any pill.

Are GLP-1 side effects worse for women?

For hair loss, the labels show higher rates in women. In Wegovy's cardiovascular trial, hip and pelvic fractures were also more common in women on the drug, 1% versus 0.2% on placebo. For most other side effects, the labels do not break results out by sex.

References

  1. Novo Nordisk Inc. (2026). WEGOVY (semaglutide) injection and tablets — Prescribing Information: section 6.1 adverse reactions (including hair loss by sex and fractures), section 8.3 females of reproductive potential. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection — Prescribing Information: section 6.1 adverse reactions (including hair loss by sex) and section 7 oral contraceptives. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.